Russian Journal of Bioorganic Chemistry, Год журнала: 2025, Номер 51(2), С. 827 - 849
Опубликована: Апрель 1, 2025
Язык: Английский
Russian Journal of Bioorganic Chemistry, Год журнала: 2025, Номер 51(2), С. 827 - 849
Опубликована: Апрель 1, 2025
Язык: Английский
Zeitschrift für Naturforschung C, Год журнала: 2025, Номер unknown
Опубликована: Фев. 28, 2025
Abstract This study assessed the in vitro antibacterial and antibiofilm properties of new 1,3,4-thiadiazole derivatives. 1 H NMR 13 C analyses were employed to confirm structure synthesized compounds, characterization is followed by assessments their efficacy against Bacillus subtilis NRRL B478, Staphylococcus aureus ATCC 29213, Escherichia coli 25922, Pseudomonas aeruginosa 27853, as well for antifungal activity Candida albicans 90028 krusei 6258, using broth microdilution method. Notably, among tested compound 4a exhibited highest antimicrobial activity, with a minimal inhibitory concentration 125 μg/mL P. 27853 significant achieving 94 %, 98 % 100 biofilm inhibition at 250, 500 1,000 μg/mL, respectively. Besides, 4h achieved 81 89 S. 29213 respectively, displayed potent this bacterium. Finally, theoretical ADME compounds - analyzed calculations. has consolidated base development agents advanced our understanding potential mode action biofilm-associated infections.
Язык: Английский
Процитировано
0Russian Journal of Bioorganic Chemistry, Год журнала: 2025, Номер 51(2), С. 827 - 849
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0